World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   181 records for 78 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8
Recruitment statusMain ID Public TitleDate of Registration
Not recruitingNCT02141438
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
15/05/2014
RecruitingDRKS00006153
QUIPS - Quality improvement in post operative pain treatment
12/05/2014
RecruitingNCT02099409
Safety and Efficacy of Overnight Closed Loop in Children With Type 1Diabetes Mellitus in Luxembourg
26/03/2014
RecruitingNCT02042144
Safety and Effectiveness of Regorafenib
20/01/2014
RecruitingNCT02031471
TOSCARA Study: A Study of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra Treatment
16/12/2013
RecruitingNCT02018744
Multicenter, Observational Registry to Assess Outcomes With the Nellix® System for Abdominal Aortic Aneurysm Repair
18/11/2013
Not recruitingNCT01874002
Prospective Registry to Asses the Long-term Safety and Performance of the Combo Stent
06/06/2013
RecruitingNCT01849874
A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-000277-72-ITA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer 11/09/2013
AuthorisedEUCTR2013-000277-72-FIA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer 02/12/2013
AuthorisedEUCTR2013-000277-72-ESA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer16/01/2014
AuthorisedEUCTR2013-000277-72-DKA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer 05/02/2014
AuthorisedEUCTR2013-000277-72-CZA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer 01/11/2013
AuthorisedEUCTR2013-000277-72-ATA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer 14/08/2013
AuthorisedEUCTR2013-000277-72-HUA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer 23/07/2013
AuthorisedEUCTR2013-000277-72-PLA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer 13/01/2014
AuthorisedEUCTR2013-000277-72-NLA clinical study evaluating the efficacy of an investigational compound (MEK162) in adult female patients with a specific type of ovarian, fallopian tube or peritoneum cancer 19/12/2013
06/05/2013
RecruitingISRCTN17022568
Stryker NTX registry
22/03/2013
RecruitingNCT01801111
A Study of RO5424802 in Patients With Non-Small Cell Lung Cancer Who Have ALK Mutation and Failed Crizotinib Treatment
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2012-004455-36-FRSafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib. 19/04/2013
AuthorisedEUCTR2012-004455-36-ITSafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib. 05/03/2013
AuthorisedEUCTR2012-004455-36-ESSafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib.06/03/2013
AuthorisedEUCTR2012-004455-36-LUSafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib. 22/08/2013
AuthorisedEUCTR2012-004455-36-SESafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib. 22/02/2013
AuthorisedEUCTR2012-004455-36-GBSafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib. 26/02/2013
AuthorisedEUCTR2012-004455-36-NLSafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib. 14/03/2013
AuthorisedEUCTR2012-004455-36-DKSafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib. 28/05/2013
AuthorisedEUCTR2012-004455-36-DESafety and efficacy study of RO5424802 in patients with non-small cell lung cancer with ALK mutation that did not respond or stop responding to crizotinib. 05/03/2013
20/02/2013
    
1 2 3 4 5 6 7 8
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history